Company intelligence / Profile preview

Conigen Bioscience

Worcester, Massachusetts, United Statesconigen.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Conigen Bioscience develops advanced recombinant conformational proteins—both soluble and membrane-associated—that preserve native structure and function. Their proprietary platforms enable the production of bioactive tool-molecules for drug discovery, therapeutic antibody screening, immunogen design, and translational studies. The company’s products are used to improve assay sensitivity/potency and support the development of next-generation biologics such as bispecific antibodies, ADCs, CAR-T therapies, and vaccines.

Therapeutic areas: Oncology
Modalities: Recombinant proteinRecombinant antibodyVirus-like particle (VLP)Membrane protein nanoparticleSoluble multimeric protein
Industry: Drug Discovery Services

Partnerships

North Star Scientific

Beyond the preview

Go deeper on Conigen Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conigen Bioscience.

Explore the full profile